ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Oncolytics Biotech Inc. 

210-1167 Kensington Crescent

Calgary  Alberta  T2N 1X7  Canada
Phone: 403-670-7374 Fax: 403-283-0858


SEARCH JOBS


Industry
Biotechnology






 Company News
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015 9:26:46 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Primary Peritoneal Cancer 3/3/2015 7:01:22 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Cancer Of The Fallopian Tube 3/2/2015 6:57:42 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Completion Of Enrollment In Randomized Phase 2 Colorectal Cancer Study 2/18/2015 7:36:50 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Pancreatic Cancer 2/17/2015 7:48:38 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Ovarian Cancer 2/11/2015 7:40:14 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For High Grade Gliomas In Pediatric Patients 2/9/2015 8:48:52 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Designation With The European Medicines Agency For Pancreatic And Ovarian Cancers 12/22/2014 7:45:06 AM
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014 12:54:35 PM
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For Pancreatic And Ovarian Cancers 12/2/2014 11:10:02 AM
12345678910...